296 related articles for article (PubMed ID: 7000043)
1. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
Imai S; Matsubara I
Artery; 1980; 8(1):63-72. PubMed ID: 7000043
[TBL] [Abstract][Full Text] [Related]
2. [Study of platelet aggregation by the filtration pressure method (author's transl)].
Matsubara I
Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):173-84. PubMed ID: 7035311
[TBL] [Abstract][Full Text] [Related]
3. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
Fletcher JR; Ramwell PW
Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
[TBL] [Abstract][Full Text] [Related]
4. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
Szekeres L; Krassói I; Pataricza J; Udvary E
Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
Hermán F; Hadházy P; Magyar K
Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
[TBL] [Abstract][Full Text] [Related]
6. Control of human and animal platelet aggregation by a new prostacyclin analog.
Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
[TBL] [Abstract][Full Text] [Related]
7. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
Weselcouch EO; Humphrey WR; Aiken JW
J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
[TBL] [Abstract][Full Text] [Related]
8. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
Pedvis LG; Wong T; Frojmovic MM
Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
[TBL] [Abstract][Full Text] [Related]
10. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
11. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation.
Aiken JW; Gorman RR; Shebuski RJ
Prostaglandins; 1979 Apr; 17(4):483-94. PubMed ID: 111306
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
[TBL] [Abstract][Full Text] [Related]
13. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
Whittle BJ; Moncada S; Vane JR
Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
[TBL] [Abstract][Full Text] [Related]
14. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
Pataricza J; Bor P; Szekeres L
Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the disaggregating effect of prostacyclin (PGI2) in anaesthetized dogs.
Hermán F; Hadházy P; Magyar K
Biomed Biochim Acta; 1984; 43(8-9):S377-80. PubMed ID: 6393972
[TBL] [Abstract][Full Text] [Related]
16. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
17. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs.
Zhao G; Xu X; Ochoa M; Shen W; Hintze TH
Cardiovasc Res; 1996 Nov; 32(5):940-8. PubMed ID: 8944825
[TBL] [Abstract][Full Text] [Related]
18. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
Hemker DP; Shebuski RJ; Aiken JW
J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
[No Abstract] [Full Text] [Related]
19. Effects of prostacyclin on tumor cell-induced platelet aggregation.
Menter DG; Onoda JM; Taylor JD; Honn KV
Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
